Allen Koester speaking at the ISPE 2024 Annual Meeting

Salas O’Brien expert, Allen Koester, is presenting at the ISPE on Realizing Our Bold Sustainability Ambition with Kevin Conkright of AstraZeneca, Monday, October 14th at 11:15 am EST.

The pharmaceutical industry is a customer focused industry that puts its patients first, and a sustainable process is healthy for the environment — which supports a healthy patient. AstraZeneca has a bold sustainability ambition which includes being carbon neutral by 2025. This presentation focuses on the journey of the Mt. Vernon AstraZeneca Supply Site to becoming a sustainable manufacturing facility achieving carbon neutrality by 2025. This session highlights a true corporate commitment, the role of technical partnerships, the importance of engaging your team across all levels, and of capitalizing on both big and small opportunities.

Allen Koester is a professional engineer and certified project manager with 35 years of experience, including 31 in FDA-regulated environments. He has led large capital projects exceeding $150M, from concept to implementation, and has broad knowledge of major engineering and construction installations. Currently, he serves as a senior project manager, overseeing complex, multi-discipline projects. With nearly 30 years of sustainability work, Allen works closely with clients to define goals and coordinates teams to deliver successful outcomes. He retired from AstraZeneca in 2016 and now holds a Senior Vice President role at Salas O’Brien.

For more information, visit the ISPE 2024 Annual Meeting site.

Through my work with global colleagues in ISPE I have gained a renewed appreciation for Sustainability. The Pharmaceutical industry is deeply committed to its patients and sustainability plays a vital role in supporting their health by taking care of the environment. Project ROI’s can drive decisions but caring for our environment through sustainability measures is always the right thing to do. As my mother always said: “ Waste Not, Want Not.”

Allen Koester, PE, PMPSenior Vice President, Salas O’Brien

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is a nonprofit association serving its members by leading scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. ISPE is the global industry leader in connecting pharmaceutical knowledge to deliver manufacturing and supply chain innovation, operational excellence, and regulatory insights to enhance industry efforts to develop, manufacture and reliably deliver quality medicines to patients.

About Salas O’Brien

Salas O’Brien is an engineering and technical services firm focused on advancing the human experience through the built environment. Our team is engineered for impact, helping clients achieve critical goals, advancing our team members through growth and opportunity, and operating at the center of important global issues including sustainability and decarbonization. We are a top firm as ranked by Engineering News-Record and Consulting-Specifying Engineer, and we have appeared for the past ten years on the Inc. 5000 list of North America’s fastest-growing private companies.

For more details or to set up an interview, please contact Stacy Lake, Director of Corporate Communications.

Topics

Speakers